Company: CORT
Filing Date: 2025-05-05
Form Type: 10-Q
Source: 0001628280-25-022173
Chunk: 6

Company: CORCEPT THERAPEUTICS INC
Filing Date: 2025-05-05
Form: 10-Q
Item: Part I, Item 1
Chunk 6
---
 goods8,499 8,206 Total inventory15,534 15,995 Less strategic inventory classified as non-current(1,166)(3,583)Total inventory classified as current$14,368 $12,412 We have purchased and hold significant quantities of active pharmaceutical ingredient (“API”), included in work in progress inventory. We classify inventory we do not expect to utilize within 12 months of the balance sheet date as “strategic inventory,” a non-current asset.Prepaid expenses and other current assetsMarch 31,2025December 31,2024 (in thousands)Prepaid expenses$8,554 $9,492 Deferred clinical materials4,316 4,493 Clinical deposits1,817 1,817 Other current assets24,866 6,078 Total prepaid expenses and other current assets$39,553 $21,880 As of March 31, 2025, other current assets included $18.2 million of non-trade receivables relating to proceeds from stock option exercises.Accrued and other liabilitiesMarch 31,2025December 31,2024 (in thousands)Government rebates$44,232 $41,580 Accrued compensation36,420 41,731 Accrued selling and marketing costs4,197 3,345 Other4,026 4,044 Total accrued and other liabilities$88,875 $90,700 Other assetsAs of each of March 31, 2025 and December 31, 2024, other assets included $5.6 million of deposits for clinical trials.

9

3. Available-for-Sale Marketable Securities and Fair Value Measurements

The available-for-sale securities in our condensed consolidated balance sheets are as follows:March 31,2025December 31,2024(in thousands)Cash equivalents$69,663 $98,436 Short-term marketable securities232,944 255,669 Long-term marketable securities248,041 219,831 Total marketable securities$550,648 $573,936 The following table presents our available-for-sale securities grouped by asset type: Fair ValueHierarchyLevelMarch 31, 2025December 31, 2024Amortized CostGross Unrealized GainsGross Unrealized LossesEstimated Fair ValueAmortized CostGross Unrealized GainsGross Unrealized LossesEstimated Fair Value  (in thousands